
HotSpot Therapeutics Presents Preclinical Data from Small Molecule IRF5 Inhibitor Program at EULAR 2026
<a href="https://news.google.com/rss/articles/CBMi2wFBVV95cUxQOWgzQnhjVWpRZ1dsMVFQcmVjeVpkUkZWYkxjRGFoSURXZGdmMVhxZ0hhem5xcjhIbkMtWFZMMWsyS0tNSlpHVkt1NlQwN0FIWHg5OXE0UFd4ZWFwa3JZZHdoQl94aFExWWFZMzN5Q256UUZMaFMyNnZCTEpxbjh5a3A4UWVfc0xVbEtZTGdmOFdTWDdBZjA5THdNb0hPU1l6c3g5eFNnMHNQU2RrSHdmVWE2Yjdtam1FbjZCMWZ1ME5uN05BYU9WV045QVVVbDgxSU5TQ3lDMHhtTms?oc=5" target="_blank">HotSpot Therapeutics Presents Preclinical Data from Small Molecule IRF5 Inhibitor Program at EULAR 2026</a>&nbsp;&nbsp;<font color="#6f6f6f">BioSpace</font>
